Description
How it works?
Tasigna capsule 200 mg 28’s works by slowing or stopping the growth of cancer cells.
Tasigna Capsule Uses
What is the medicine used for?
- Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
This drug is used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in patients with resistance or intolerance to prior therapy.
Concerns
Asked Frequently Questions
- Start the process
The length of time required for this drug to exert action has not been clinically established.
- Duration of Effect
The length of time this drug remains active in the body has not been determined clinically.
- Being safe with alcohol?
Alcohol interaction is unknown. Consult your doctor before eating.
- Is it habit forming?
No trends in habit formation were reported.
- Usage in pregnancy?
This medication is not recommended for use in pregnant women unless absolutely necessary. Discuss the risks and benefits with your doctor before taking this medicine.
- Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Discuss the risks and benefits with your doctor before taking this medication. Your doctor may advise you to stop breastfeeding or stop taking medication, depending on your condition.
When not to use it?
Allergy
This medicine is contraindicated in patients with known allergies to Tasigna capsule 200 mg 28’s or other inactive ingredients.
Hypokalemia
This drug should not be used in patients with hypokalemia (low blood potassium) as it may worsen the patient’s condition.
Hypomagnesemia
This drug is not recommended for patients with hypomagnesemia (low magnesium in the blood), as it can worsen the patient’s condition.
QT interval prolongation
This drug is not recommended in patients with a prolonged QT interval as it is more likely to worsen the condition.
Pregnancy
This medication is not recommended for use in pregnant women unless absolutely necessary. Discuss the risks and benefits with your doctor before taking this medication.
Breast feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Discuss the risks and benefits with your doctor before taking this medication. Your doctor may advise you to stop breastfeeding or stop taking medication, depending on your condition.
Electrolyte imbalances
Electrolyte imbalances such as sodium, potassium and phosphates have been reported in patients taking Tasigna capsule 200 mg 28’s . Careful monitoring of blood electrolyte levels is important for patients receiving this medication. Appropriate corrective measures, dose adjustments, or replacement with an appropriate alternative may be required depending on the clinical condition.
Driving or operating machinery
Use of this drug can cause dizziness and loss of vision. Therefore, it is advised that you do not engage in activities that require high mental alertness, such as driving or operating machinery, if you experience any symptoms while taking this medication.
Stimulation of bone marrow
This drug should be used with caution in patients with thrombocytopenia, agranulocytosis, anemia, or bone marrow suppression as further complications may worsen the patient’s outcome. Before taking this medication, you should have a complete blood count. It is important to maintain good blood counts while on this medication. Appropriate dose modification or replacement with an appropriate alternative may be required depending on the clinical condition.
VENDOR: NOVARTIS PHARMA (PAK) LTD
INGREDIENTS: NILOTINIB
Generic Category: Anti-Cancer
Ingredients: Nilotinib
Strength: 200mg
Pack Size: 28’s
Prescription Required: No
Original & Imported
Manufacturer: Novartis Pharma (Pak)
Country of Origin: Imported
Pack Form: Pack of 28 Capsules
Product Form: Capsules
Product Type: Medicine
Usage and Safety Information
Key Highlights: Nilotinib is used to treat certain types of chronic myeloid leukemia (Cml; a type of cancer of the white blood cells) who have recently found to have this condition in adults and children 1 year of age and older.
Storage: Store in a dry place, at or below 25 °C . Protect from direct sunlight.
Habit Forming: No
Sedation: No
Child Safety: No
Route of Administration: Oral
Reviews
There are no reviews yet.